Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TS-022 in Adult Patients With Atopic Dermatitis
NCT00914186Phase 2Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Jun 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TS-022 in atopic dermatitis (AD), sponsored by Taisho Pharmaceutical. Started Jun 2009; status: completed.
02
Drugs
TS-022
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00914186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914186.